Aurora Cannabis Inc. (ACB)
ACB Stock Price Chart
Explore Aurora Cannabis Inc. interactive price chart. Choose custom timeframes to analyze ACB price movements and trends.
ACB Company Profile
Discover essential business fundamentals and corporate details for Aurora Cannabis Inc. (ACB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
15 Jul 2014
Employees
1.07k
Website
https://www.auroramj.comCEO
Miguel Martin
Description
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.
ACB Financial Timeline
Browse a chronological timeline of Aurora Cannabis Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is -$0.13, while revenue estimate is $48.52m.
Earnings released on 11 Jun 2026
EPS came in at -$0.35 falling short of the estimated -$0.07 by -392.97%, while revenue for the quarter reached $60.98m , beating expectations by +12.05%.
Earnings released on 4 Feb 2026
EPS came in at $0.09 falling short of the estimated $0.10 by -7.42%, while revenue for the quarter reached $68.59m , beating expectations by +1.97%.
Earnings released on 5 Nov 2025
EPS came in at $0.09 surpassing the estimated $0.03 by +200.00%, while revenue for the quarter reached $64.88m , beating expectations by +4.57%.
Earnings released on 6 Aug 2025
EPS came in at -$0.19 falling short of the estimated $0.18 by -205.56%, while revenue for the quarter reached $72.00m , beating expectations by +1.75%.
Earnings released on 18 Jun 2025
EPS came in at $0.07 falling short of the estimated $0.11 by -36.36%, while revenue for the quarter reached $62.91m , beating expectations by +1.93%.
Earnings released on 5 Feb 2025
EPS came in at $0.06 surpassing the estimated $0.00 by +1.69k%, while revenue for the quarter reached $61.29m , beating expectations by +10.43%.
Earnings released on 6 Nov 2024
EPS came in at $0.04 surpassing the estimated -$0.22 by +118.18%, while revenue for the quarter reached $59.95m , beating expectations by +16.29%.
Earnings released on 7 Aug 2024
EPS came in at -$0.11 surpassing the estimated -$0.35 by +68.57%, while revenue for the quarter reached $60.97m , beating expectations by +7.57%.
Earnings released on 20 Jun 2024
EPS came in at -$0.11 surpassing the estimated -$0.18 by +38.89%, while revenue for the quarter reached $49.76m , missing expectations by -3.07%.
Stock split effective on 20 Feb 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 Feb 2024
EPS came in at -$0.38 falling short of the estimated -$0.10 by -277.25%, while revenue for the quarter reached $48.60m , beating expectations by +1.63%.
Earnings released on 9 Nov 2023
EPS came in at -$0.05 falling short of the estimated -$0.04 by -25.00%, while revenue for the quarter reached $46.67m , beating expectations by +36.12%.
Earnings released on 10 Aug 2023
EPS came in at -$0.40 falling short of the estimated -$0.39 by -1.97%, while revenue for the quarter reached $56.66m , missing expectations by -0.36%.
Earnings released on 14 Jun 2023
EPS came in at -$1.50 falling short of the estimated -$0.07 by -2.04k%, while revenue for the quarter reached $52.70m , beating expectations by +4.91%.
Earnings released on 9 Feb 2023
EPS came in at -$0.20 falling short of the estimated -$0.08 by -150.00%, while revenue for the quarter reached $47.23m , missing expectations by -1.50%.
Earnings released on 10 Nov 2022
EPS came in at -$0.80 falling short of the estimated -$0.62 by -28.36%, while revenue for the quarter reached $44.58m , beating expectations by +10.22%.
Earnings released on 20 Sept 2022
EPS came in at -$0.80 falling short of the estimated -$0.20 by -300.00%, while revenue for the quarter reached $44.26m , missing expectations by -2.77%.
Earnings released on 12 May 2022
EPS came in at -$10.40 falling short of the estimated -$1.60 by -550.00%, while revenue for the quarter reached $43.89m , missing expectations by -19.74%.
Earnings released on 10 Feb 2022
EPS came in at -$4.20 falling short of the estimated -$1.70 by -147.06%, while revenue for the quarter reached $47.51m , beating expectations by +1.81%.
Earnings released on 9 Nov 2021
EPS came in at -$0.90 surpassing the estimated -$1.80 by +50.00%, while revenue for the quarter reached $47.41m , missing expectations by -41.57%.
Earnings released on 27 Sept 2021
EPS came in at -$2.10 surpassing the estimated -$2.20 by +4.55%, while revenue for the quarter reached $44.05m , beating expectations by +14.75%.
ACB Stock Performance
Access detailed ACB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
